A chronic inflammatory disorder of the airways affecting both children and adults, asthma had an estimated 262 million sufferers worldwide in 2019. While conventional medicine has no cure for the condition, many patients have seen significant improvements through using science-based nutritional and Cellular Medicine approaches. Providing further support for this promising therapeutic direction, a recent study found low serum levels of zinc, selenium, and vitamin D3 in asthmatic children and confirmed that these insufficiencies are associated with airway inflammation and poor asthma control.
Such findings are clearly consistent with the key principles of Dr. Rath’s Cellular Medicine approach, which describe how micronutrient deficiencies are the primary cause of today’s most common chronic diseases. For some asthma patients, preventing these deficiencies could literally be lifesaving. According to the World Health Organization, a total of 455,000 deaths worldwide were attributed to asthma in 2019.
The financial costs of the disorder are also considerable. In 2013, the economic burden of asthma in the United States alone was estimated to be $81.9 billion. Conventional medicine offers little hope that this cost will be reduced anytime soon. In contrast, nutritional and Cellular Medicine approaches have the potential to transform both the prevention and treatment of asthma. In the interests of patients and their families, it is time for these therapies to be made as freely and widely available as possible.
To learn about the benefits of Dr. Rath’s micronutrient synergy approach in the prevention and control of asthma, see this article on our website.
Moderna is Spying on You
November 30, 2023Pesticide Levels In The Body Are Significantly Reduced Six Days After Starting An Organic Diet
December 1, 2023Clinical Trial Data Suggests Prenatal Vitamin D Reduces a Child’s Risk of Asthma
News
A review of 15 years’ worth of data from the Vitamin D Antenatal Asthma Reduction Trial found that vitamin D supplementation during pregnancy reduced rates of asthma and wheezing in children.
[Source: medicalxpress.com]
Comment
A chronic inflammatory disorder of the airways affecting both children and adults, asthma had an estimated 262 million sufferers worldwide in 2019. While conventional medicine has no cure for the condition, many patients have seen significant improvements through using science-based nutritional and Cellular Medicine approaches. Providing further support for this promising therapeutic direction, a recent study found low serum levels of zinc, selenium, and vitamin D3 in asthmatic children and confirmed that these insufficiencies are associated with airway inflammation and poor asthma control.
Such findings are clearly consistent with the key principles of Dr. Rath’s Cellular Medicine approach, which describe how micronutrient deficiencies are the primary cause of today’s most common chronic diseases. For some asthma patients, preventing these deficiencies could literally be lifesaving. According to the World Health Organization, a total of 455,000 deaths worldwide were attributed to asthma in 2019.
The financial costs of the disorder are also considerable. In 2013, the economic burden of asthma in the United States alone was estimated to be $81.9 billion. Conventional medicine offers little hope that this cost will be reduced anytime soon. In contrast, nutritional and Cellular Medicine approaches have the potential to transform both the prevention and treatment of asthma. In the interests of patients and their families, it is time for these therapies to be made as freely and widely available as possible.
To learn about the benefits of Dr. Rath’s micronutrient synergy approach in the prevention and control of asthma, see this article on our website.
Dr. Rath Health Foundation
Related posts
France Records Growing Number of Supercentenarians
Read more